DAYLI Partners
Venture capitalSeoul · Seed–Late Stage
Investment thesis
DAYLI Partners positions itself as a specialized investment group focused on the bio and healthcare industries as well as finance and corporate governance. Leveraging differentiated expertise and strong execution capabilities, the firm seeks to lead industry evolution and innovation through its investments, with the goal of creating sustainable performance and returns.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 5 of 116 portfolio companiesBiotech ×3Healthtech ×3Deep Tech ×1Hardware ×1Medical Devices ×1
HQs:South Korea×2Indonesia×1
Investments · 116 tracked
founders shown can be your intro path
Alodokter runs an Indonesian health platform that combines medical reference articles with direct chat access to licensed doctors.
Healthtech
Suci Arumsari(Founder)inNathanael Faibis
Co-investors500 GlobalGolden Gate VenturesWessel ManagementMDI VenturesSamsung Ventures
Arum Therapeutics is a drug development company focused on identifying and targeting novel biological targets and signaling pathways to create new therapeutics.
Biotech
Mark Taegon Baik(Founder)in
Co-investorsAju IB Invesment Corporation
Carus Bio develops next-generation in vivo CAR-T therapeutics using an mRNA delivery platform technology for cell and gene therapy.
BiotechDeep TechHealthtech
CMES Robotics develops AI-based 3D vision software that lets industrial robots pick and handle unstructured objects.
Co-investorsAtinum Investment Co. Ltd.Kiwoom Investment
DD Pharmatech develops therapeutics for metabolic disorders, with a focus on oral and long-acting GLP-1 receptor agonist formulations.
Biotech
Seulki Lee(Executive Officer, Director)Sunghoon Hong(Executive Officer, Director)Sungmook Lim(Executive Officer, Director)
BoardDaehyun Shin(Director)Seungwon Lim(Director)Seol-Heui Han(Director)
Co-investorsLB InvestmentOctave Ventures Llc
SKINGRAB is a South Korean manufacturer of energy-based aesthetic medical devices, including its FINIFF system, aimed at skincare professionals and patients.
HardwareHealthtechMedical Devices
Co-investorsPremier Partners
Exits · 1
IPOs and acquisitions across the tracked portfolioTrinity BiotechNASDAQ: TRIB
Portfolio news
latest coverage across their companiesD&D Pharmatech · eu-startups.com · Jul 20, 2026
Frequently asked questions
- How many investments has DAYLI Partners made?
- DAYLI Partners has 115 tracked investments, including 1 dated in the last 24 months.
- What stage does DAYLI Partners invest at?
- DAYLI Partners invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does DAYLI Partners focus on?
- DAYLI Partners focuses on Biotech, Digital Health, Fintech, Healthtech, Medical Devices.
- Where is DAYLI Partners located?
- DAYLI Partners is headquartered in Seoul, KR.
- Who does DAYLI Partners co-invest with?
- DAYLI Partners most often shares deals with Atinum Investment Co. Ltd., Kiwoom Investment, LB Investment, among 6 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.